贝叶斯适应性随机试验混合认知行为疗法在稳定扩散质瘤中治疗严重疲劳
Maxine Gorter1,2, Jantine G Röttgering2,3, Vera Belgers2,4
1Amsterdam UMC location Vrije Universiteit Amsterdam, Anatomy and Neurosciences, Amsterdam, The Netherlands.
Neuro-oncology
|November 9, 2025
概括
混合认知行为疗法 (bCBT) 在扩散性质瘤患者中显著降低了严重疲劳. 这种基于证据的治疗也改善了焦虑和生活质量,提供了新的支持性护理策略.
科学领域:
- 神经瘤学神经瘤学
- 心理干预 心理干预
- 临床试验研究临床试验研究
背景情况:
- 严重的疲劳是被诊断患有扩散性质瘤的患者的普遍和衰弱症状.
- 目前,没有确立的基于证据的治疗方法可以有效地管理这种患者群体的严重疲劳.
- 这项研究旨在解决在扩散性质瘤患者中有效的疲劳管理策略的未满足需求.
研究的目的:
- 评估混合认知行为疗法 (bCBT) 在减轻扩散性质瘤患者严重疲劳的疗效.
- 评估BCBT对二次结果的影响,包括与健康相关的生活质量 (HRQoL),焦虑,未来的不确定性和抑郁.
主要方法:
- 一项随机对照试验 (RCT) 针对严重疲劳的患者进行 (检查清单个人强度,疲劳-严重性子表 [CIS-疲劳] ≥35) 具有稳定的扩散性质瘤.
- 参与者被随机分配到接受12周的bCBT或等待列表条件 (WLC).
- 采用贝叶斯适应性设计与中间分析,评估干预后2周的主要终点和干预后2周和12周的次要结果.
主要成果:
- 由于支持bCBT的压倒性证据,该试验因有效性而提前停止.
- 较高的后部概率 (99.94%) 表示bCBT与WLC的CIS疲劳得分较低,效果大小很大 (科恩的d=1.12).
- 在疲劳严重程度 (68%不再严重疲劳后bCBTvs24%在WLC),焦虑,HRQoL和未来不确定性中观察到显著的改善.
结论:
- 混合认知行为疗法 (bCBT) 是一种高效的干预措施,用于减少扩散性质瘤患者的严重疲劳.
- 在这个患者群体中,bCBT在改善焦虑和与健康有关的生活质量方面显示出显著的好处.
- 这些发现支持将BCBT整合到扩散性质瘤患者的支持性护理策略中,以提高整体幸福感.
更多相关视频
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
1.5K
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.8K
相关概念视频
Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
